OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Peter Choyke Discusses Molecular Imaging Research

September 6th 2012

Dr. Peter Choyke, from the National Cancer Institute, Molecular Imaging Program, Discusses Current Molecular Imaging Research.

Dr. Howard Burris Discusses the mTOR Inhibitor Everolimus

September 5th 2012

Dr. Howard Burris, from the Sarah Cannon Research Institute, Discusses the mTOR Inhibitor Everolimus for HER2-Negative Breast Cancer.

Dr. Gralow Discusses the Antibody Drug Conjugate T-DM1

September 4th 2012

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, Discusses the Antibody Drug Conjugate T-DM1 for Breast Cancer.

Donna Berry Discusses Nurse-Led Patient Education

August 31st 2012

Donna Berry, from the Dana-Farber Cancer Institute, Explains a Nurse-Led Education Program That Enhanced Oral Therapy Compliance.

Dr. Scagliotti on Targeted Therapies and Chemotherapy

August 31st 2012

Dr. Giorgio Scagliotti, from the University of Turin, San Luigi Hospital, on Combining Targeted Therapies With Chemotherapy for Lung Cancer Patients.

Dr. Mohler Discusses Prostate Cancer Trial Endpoints

August 30th 2012

Dr. James Mohler, from Roswell Park Cancer Institute, Discusses the Need for Intermediate Endpoints for Early Stage Prostate Cancer Trials.

Dr. Sekulic on the Hedgehog Pathway Inhibitor Vismodegib

August 30th 2012

Dr. Aleksandar Sekulic, from the Mayo Clinic in Arizona, on the Hedgehog Pathway Inhibitor Vismodegib for Basal Cell Carcinoma.

Dr. Langer Discusses Treating Locally Advanced NSCLC

August 29th 2012

Dr. Corey Langer, from the University of Pennsylvania, Abramson Cancer Center, Discusses Treating Locally Advanced Non-small Cell Lung Cancer.

Dr. Rugo on Antiangiogenic Therapies in Breast Cancer

August 28th 2012

Dr. Hope Rugo, from the UCSF Helen Diller Family Comprehensive Cancer Center, Examines Angiogenesis Inhibition Trials in Advanced Breast Cancer.

Dr. Louis Weiner Discusses the T-DM1 EMILIA Trial

August 27th 2012

Dr. Louis Weiner, from the Lombardi Comprehensive Cancer Center, Discusses the T-DM1 EMILIA Trial for HER2-Positive Breast Cancer.

Dr. Ribas on MAPK Inhibition With Dabrafenib and Trametinib

August 23rd 2012

Dr. Antoni Ribas, from UCLA Jonsson Comprehensive Cancer Center, on the Benefits of MAPK Inhibition With Dabrafenib and Trametinib

Dr. Camidge Discusses Resequencing Lung Cancer

August 23rd 2012

Dr. Ross Camidge, from the University of Colorado Cancer Center, Discusses Resequencing Lung Cancer

Suzanne Fuqua on Utilizing Predictive Biomarkers

August 21st 2012

Suzanne Fuqua, PhD, from the Baylor College of Medicine, on the Utilization of Predictive Biomarkers

Elaine Mardis on Sensitivity to Aromatase Inhibitors

August 20th 2012

Elaine Mardis, from the Genome Institute at Washington University School of Medicine, on Sensitivity to Aromatase Inhibitors

Dr. Herbst Explores Molecular Testing in Lung Cancer

August 15th 2012

Dr. Roy S. Herbst, from Yale Cancer Center, Explores Molecular Testing in Lung Cancer

Robin McConnell Discusses Nutrition in Cancer Care

August 14th 2012

Robin McConnell, from John Theurer Cancer Center, Discusses Nutrition in Cancer Care

Dr. Ryan on the Unblinding of the COU-AA-302 Trial

August 13th 2012

Dr. Charles Ryan from the UCSF Helen Diller Family Comprehensive Cancer Center Discusses the Unblinding of the COU-AA-302 Trial

Paul Jacobsen Discusses Survivorship Care Plans

August 10th 2012

Paul Jacobsen, from the H. Lee Moffitt Cancer Center and Research Institute, Discusses Survivorship Care Plans

Dr. Gandara Discusses Molecular Testing for NSCLC

August 9th 2012

Dr. David Gandara, from University of California, Davis Comprehensive Cancer Center, discusses using the multiplexing assay for patients with non-small cell lung cancer

Dr. Ambinder on the Potential Impact of SIRI on Health IT

August 8th 2012

Dr. Edward Ambinder, from Mount Sinai School of Medicine, on the Potential Impact of using Apple's SIRI to aid Health Information Technology.